Fc-mediated immune modulation has been examined, T cells or macrophages appear to be involved (40) (41) (42) (43) (44) (45) (46) . There is one system however, where the B cell is apparently directly affected by Fc binding of IgG (47) . B cells treated with whole rabbit anti-mouse IgM do not induce B cells to proliferate, although F(ab')2 fragments do. Recent results (48) indicate that whole anti-Ig does lead to B cell depolarization, enlargement, and enhanced Ia antigen expression. Thus, although B cells become activated by whole anti-Ig, Fc-mediated binding of the anti-Ig seems to inhibit DNA synthesis. The crosslinking of surface Ig (sIg) ~ to Fc receptors appears to act as a regulatory signal acting directly on the B cell.
To better understand this potentially important B cell receptor(s), we have begun to characterize those capable of binding IgG. Our results indicate that a single Fc receptor binds both rat and mouse IgGs of the IgG1, IgG2a, and IgG2b subclasses. Furthermore, we find that B cells of A/J, AL/N, and NZB/J mice bind 3.5-7-fold less rat IgG than B cells of other strains, reflecting a difference in the specificity of the IgG Fc receptor rather than a difference in the number of Fc receptors expressed by A/J B lymphocytes. An examination of backcross mice and Igh recombinant mouse strains indicates that Fc receptor polymorphism is loosely linked to the Igh locus of chromosome 12 and maps telomeric to the prealbumin locus.
Materials and Methods
Mouse Strains. Adult BALB/cJ, C57BL/6J, C57BL/10J, SjL/j, DBA/2J, AKR/J, A/J, a/HeJ, NZB/BLJ, CE/J, P/J, CBA/J, C3H/FeJ, and PL/J mice were obtained from The Jackson Laboratory (Bar Harbor, ME) and breeding facilities at Washington University. AL/N, C.AL9, and C.AL20 mice were obtained from Dr. Michael Potter (NIH,
Betbesda, MD).
Igh recombinant mouse strains, AXC and CXAXCB were constructed by crossing mice with different allotypes and selecting for recombination between the Igh-V marker locus (IgH-Dex) and the Igh-C marker allotype, or for recombinations between Igh-C and Pre-l, the serum prealbumin locus (49) (50) (51) .
Cells and Culture Conditions. Normal lymphoid cell populations were separated into T and B cells by panning. Polystyrene dishes (16 x 100 mm, No. 1001; Falcon Labware, Oxnard, CA) were coated with affinity-purified goat anti-mouse IgM or mouse anti-rat Ig according to the method of Wysocki and Sato (52) . Briefly, 5-10 ml of purified antibody (10 #g/ml) in 0.05 M Tris, 0.15 M NaCI, pH 9.5 was added to polystyrene dishes for 1 h at room temperature. Dishes were then washed in phosphate-buffered saline (PBS)/1% fetal calf serum (FCS) and further incubated in PBS/1% FCS to block remaining protein-binding sites. For indirect panning, plates coated with mouse anti-rat Ig were incubated with appropriate amounts of monoclonal antibody 14.8, directed to the B cell marker B220 (53) or monoclonal anti-Thy-l.2 (Jlj) (54) for 1 h at room temperature. Plates were thoroughly washed and spleen cells (2 x 107) were gently layered onto the plates in Dulbecco's modified Eagle's medium (DME), 5% FCS and incubated at 4°C for 60 min. Nonadherent cells were removed in eight washes after which adherent cells were harvested by vigorous pipeting.
T and B cell blasts were induced by mitogen stimulation and purified on Percoll density gradients in some experiments. Briefly, spleen cells were treated with either concanava[in A (Con A) (2 ~g/ml) or lipopolysaccharide (LPS) (50 t~g/ml). Cells were cultured in DME supplemented with glucose, sodium bicarbonate, nonessential amino acids, glutamine, i Abbreviations used in this paper: AV, avidin; BSA, bovine serum albumin; Con A, concanavalin A; DME, Dulbecco's modified Eagle's medium; DNP, dinitrophenyl; FACS, fluorescence-activated cell sorter; F1TC, fluorescein isothiocyanate; FCS, fetal calf serum; LPS, lipopolysaccharide; PBS, phosphate-buffered saline; PE, phycoerythrin; slg, surface immunoglobulin. penicillin, streptomycin, 10% FCS, and 5 x 10 -5 M 2-mercaptoethanol. Cultures were maintained in a humidified incubator at.37°C with 5% CO2, 7% 02, 88% N2. Con Atreated cells were harvested on day 2 after stimulation and LPS blasts were collected on day 3. The blasts were then isolated and analyzed by fluorescence-activated cell sorter (FACS).
Fluorescent Antibody-bindingAssay. 4 × 105 cells in DME/0.5% bovine serum albumin (BSA)/0.02 M NaN3 were placed in individual wells of V-bottom 96-well microtiter dishes (Dynatech Laboratories, Alexandria, VA), and optimal amounts of antibodies in a volume of 30 #1 were added to each well. Cells were incubated on ice for 30 min. Each sample was underlaid with 10% BSA in DME containing 0.02 M NaN3 and centrifuged at 250 × g for 10 min. This step was repeated after aspiration of the supernatant and resuspension of the cells. After the second wash, cells were resuspended in 25 zl of fluorescin isothiocyanate (FITC)-mouse anti-rat Ig or FITC-goat anti-mouse IgG (Southern Biological Associates, Birmingham, AL) for 30 rain on ice. FITC-mouse anti-rat Ig and FITCgoat anti-mouse IgG were spun at 120,000 g for 30 min to remove aggregated antibody. Samples were underlaid with BSA and centrifuged as before. Cells were resuspended in 50 t~l DME/0.5% BSA/0.02 M NaNz containing 10 #g/ml propidium iodide (Sigma Chemical Co., St. Louis, MO). Propidium iodide (red fluorescence) was used to exclude dead cells from analysis (55) . Biotin-conjugated antibodies were also used in combination with FITC-avidin (AV) or phycoerytbrin (PE)-AV to detect cells (56) . PE was obtained from Molecular Probes, Junction City, OR. In dual-fluorescence studies, the procedure outlined above was duplicated except that a rat anti-mouse kappa (hybridoma 187. I) (57) conjugated to PE was used to identify B cells. Cells were analyzed on a FACS IV equipped with an argon ion laser tuned to 488 nm and operating at 200 mW of power. Photomultiplier tube voltage and gain setting were constant throughout all experiments. Fluorescence histograms were generated with logarithmic amplification (log base 10) of fluorescence emitted by single viable cells.
Inhibition Assays. Titrations of the biotin-conjugated or FITC-labeled IgG were performed to determine at which point slightly less than maximal staining was observed, so that labeled IgG was limiting. The fluorescence assay used to detect optimal Ig binding to B lymphocyte Fc receptors requires approximately 10-100 times the concentration of purified antibodies that provides optimal staining for immunofluorescence when using antibodies specific for cell surface determinants. Under conditions where labeled IgG is limiting, inhibition by unlabeled IgGs can be quantitated. Aggregated myeloma or hybridoma isotype standards were titrated into a constant number of cells (3 × 105) and allowed to incubate for 5 min. A constant amount (~50/zg/ml) of labeled IgG is then added at 4°C for 25-30 rain. The cells are washed and analyzed for fluorescence, as described above. Inhibition was measured as the decrease in relative fluorescence intensity caused by the competing IgG.
Myeloma and Hybridoma Antibody Standards. Murine myeloma proteins were obtained
by injecting MOPC-21 (IgG1), MPC-11 (IgG2b), LPC-1, UPC-10 (IgG2a), or J606 (IgG3) cells into the peritoneal cavity of pristane-primed BALB/c mice (61) . The ascites fluid was precipitated with 50% saturated ammonium sulfate. The proteins were isolated by DEAE chromatography and preparative isoelectric focusing. Affinity-purified murine hybridomas 32-1A (IgG2a, anti-dinitrophenyl [DNP]), 29-13 (IgG2b, anti-DNP), and HDP-1 (IgG1, anti-DNP) (kindly provided by Dr. M. Scott, Mallinckrodt, Inc., St. Louis, MO) were also used as isotype standards.
Rat hybridoma antibodies of IgG1, IgG2a, IgG2b, and IgG2c isotypes were produced in our laboratory using standard methods. The affinity-purified antibodies used in these studies were: IgG1 (49C2D3, anti-DNP), IgG2a (50C1C1, anti-DNP), IgG2b (148d4-1, anti-N-acetylglucosamine), and IgG2c (120 a3-5, antiphosphorylcholine). EA4.1 (IgG2b, unknown specificity) was also used in these studies as an isotype standard. Rat myeloma proteins IR595 (IgG 1) and IR418 (IgG2a) were kindly provided by Dr. H. Bazin (University of Louvain, Belgium) (62) . Aggregated immunoglobulins were produced using bisdiazotized benzidine (63) or by heat aggregation.
Results

IgG Binding to Mouse B Lymphocyte Fc Receptors.
In the studies reported here, we used a fluorescence assay to quantitate Fc binding of immunoglobulins to mouse B lymphocytes. The advantage of a fluorescence assay using flow microfluorometry techniques is that individual cells are analyzed for Fc receptor expression. Further, the fluorescence assay provides a strong signal that is highly reproducible between assays and is stable for several hours at 4°C. In data not shown, we found that isolated B lymphocytes (slgM +) and LPS blasts bound IgG strongly; however, we did not detect significant IgG binding to isolated T (Thy-1 ~2 +) cells or Con A blasts.
In most of the experiments, we used LPS blasts as our test population because they provide a population of pure B cells (>95%), as determined by expression of sIg and B220. Each of the mouse IgG subclasses, IgG1, IgG2a, and IgG2b (Fig. 1 a) and each of the rat IgG subclasses, IgG1, IgG2a, and IgG2b ( Fig. 1 b) bind to mouse B cell blasts in similar amounts.
To determine whether one or more Fc receptors was responsible for the binding of rat and mouse IgG subclasses to B cells, a series of inhibition assays were performed. The assays are based on the inhibition of a standard labeled IgG by known quantities of purified representatives of the IgG subclasses. Histograms demonstrating the inhibition of biotin-conjugated mouse IgG2a (LPC-1, UPC-10) and IgG2b (MPC-11, 29-13), as well as rat IgG2b (EA4.1), are shown in Fig. 2 , a-c, respectively. Fc-mediated binding of mouse IgG2a (LPC-1, U PC-10) is inhibited by both aggregated IgG2a (LPC-1, U PC-10) and aggregated IgG2b (MOPC-195, MPC-11) (Fig. 2a, Table I ). Similarly, the binding of the IgG2b (MPC-11, 29-13) standard is inhibited by immunoglobulins of the IgG2a (LPC-1) and IgG2b (MOPC-195, MPC-11) subclasses (Fig. 2 b, Table I ). The binding of IgG1 (HDP-1) to the Fc receptor is inhibited by IgG1, IgG2a, and IgG2b (data not shown). Thus, we conclude that the IgG1, IgG2a, and IgG2b all bind to the same Fc receptor. Further, the concentration of competing antibody that provides maximal inhibition of the IgG 1, IgG2a, or IgG2b standard proteins is the same in all cases (~750 #g/mi of LPC-1, MPC-11, MOPC-21, or MOPC-195). Fig. 2c illustrates that rat IgG2b (EA4.1, 148d4-1) is specifically inhibited by mouse IgGl (MOPC-21), IgG2a (LPC-1), and IgG2b (MPC-11).
The rat IgG2b appears to bind the mouse B cell IgG1/IgG2a/IgG2b Fc receptor, because it is inhibited by each of these subclasses. Table ! summarizes (Fig. 3 b) . The strain survey of rat IgG Fc binding is summarized in Table II (58, 60) . The Fc-binding characteristics of heterozygotes were similar to those of homozygous high binders and were clearly distinguishable from low Fc-binding mice. The results of the backcross analysis (Table III) indicate that there is loose, but significant, linkage of the Fc receptor polymorphism to the heavy chain locus. The recombination frequency is ~32% with a P value <0.005. We find no evidence for linkage to the H-2 locus as shown by H-2 congenics (Table II) or by analysis of backcross mice (Table III) ; [:n addition, no linkage was found to the x chromosome. As a further control we examined (20) . In this report, we extend these results to normal B lymphocytes that express a single Fc receptor which binds the IgG1, IgG2a, and IgG2b subclasses. In results reported elsewhere, 2 we show that there is an additional Fc receptor specific for IgG3. We also find that rat IgG1, IgG2a, and IgG2b bind to the same receptor that binds mouse IgG1, IgG2a, and IgG2b. We conclude that the B cell IgG1/IgG2a/ IgG2h receptor is probably distinct from macrophage Fc receptors, because mouse macrophages apparently possess one receptor for IgG1/IgG2b and an- other for IgG2a. In addition, clear biochemical differences occur between the IgG Fc receptors of B cell and macrophage cell lineages in mice as well as humans, although the nature of these differences remains undetermined (20, 24, 26, 65) . The other interesting observation made in this report is that a polymorphism occurs in the mouse B lymphocyte IgG Fc receptor. A strain survey shows that A/J, AL/N, and NZB/J mice bound low levels of rat IgG compared with other strains. Backcross analysis and examination of Igh recombinant strains indicate that the Fc receptor polymorphism maps telomeric to the lgh region at or near the end of chromosome 12.
Biochemical studies are currently under way to determine whether the polymorphism arises from a difference in primary structure or from differences in posttranslational modification. Recently (66), a polymorphism in an IgE-binding factor was described which is apparently the result of differences in oligosaccharide processing. The B cell Fc receptor polymorphism is expressed as a difference in the specificity of the receptor for its ligand. This polymorphism may therefore B cell blasts were exposed to normal mouse serum (NMS) or ~300 #g/ml of purified mouse IgGl, lgG2a, and IgG2b. Binding was assessed by indirect immunofluorescence and flow microfluorometry. shed some light on the nature of the IgG Fc receptor's binding site and those factors that affect the receptor's specificity. A polymorphism in the human monocyte IgG Fc receptor has recently been described (67, 68) , although no chromosomal assignment has yet been made. Furthermore, the linkage of the murine monocyte/macrophage IgG Fc receptor is unknown. Since the B cell and macrophage IgG Fc receptors differ from one another biochemically and in their specificity (26, 65 , and this report), it would be interesting to compare the linkage have reported that a single receptor activity accounts for the binding of IgG1, IgG2a, and IgG2b antibodies to murine myeloma and hybridoma cell lines, consistent with our findings.
Segregation Analysis of FcR, Igh-C, and I-A in Backcross Mice
